top of page
Search

ipsc differentiation to cardiomyocytes

  • biolabs-marketing
  • May 19, 2024
  • 1 min read

In recent decades, cardiovascular diseases were the major causes of morbidity and mortality in the world. As adult cardiomyocytes are terminally differentiated, and they are impossible to further proliferate in application of cell replacement therapy, the most promising cell types for cardiovascular regenerative medicine are human induced pluripotent stem cells (hiPSCs) which have the ability to differentiate into various cell types and proliferate in pluripotent state. The technique for differentiating iPSC into cardiomyocytes involves three stages:


Firstly, the initiation of mesoderm formation

Second, specification of cardiac lineage from mesoderm cells

Lastly, the maturation of cardiac cells


 
 
 

Recent Posts

See All
ai for antibody discovery

The creation of antibodies is the primary emphasis of the multinational corporation Creative Biolabs. We can offer a range of...

 
 
 

Comments


cataliesw

©2023 cataliesw 版權所有。透過 Wix.com 製作的理想網站

bottom of page